StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3099% above fair value
$166.43−0.10 (-0.06%)

Close on Nov 20, 2026Market cap $206.43BP/E –Yield 1.90%

Gilead Sciences Wholesaler revenue concentration by Year

Wholesaler revenue concentration — McKesson Corporation (% of total revenues) (%)

Gilead Sciences Wholesaler revenue concentration: 2,400.0% in FY2025, up 100.0 pts from a year earlier.

Latest, FY2025
2,400.0%
Period ended Dec 31, 2025
Change on a year earlier
+100.0 pts
2,300.0% in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-24) ↗

Reported in Form 10-K Note 2 Concentrations of Risk.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWholesaler revenue concentration — McKesson Corporation (% of total revenues) (%)Year on yearSource
FY2025Dec 31, 20252,400.0%+100.0 ptsForm 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 20242,300.0%-100.0 ptsForm 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 20232,400.0%+400.0 ptsForm 10-K (filed 2026-02-24) ↗
FY2022Dec 31, 20222,000.0%0.0 ptsForm 10-K (filed 2025-02-28) ↗
FY2021Dec 31, 20212,000.0%0.0 ptsForm 10-K (filed 2024-02-23) ↗
FY2020Dec 31, 20202,000.0%-200.0 ptsForm 10-K (filed 2023-02-22) ↗
FY2019Dec 31, 20192,200.0%–Form 10-K (filed 2022-02-23) ↗

Breakdown

What makes up wholesaler revenue concentration

Cite this data

StockData. (2026). Gilead Sciences Wholesaler revenue concentration (%), annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/conc-mckesson-rev

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.

See a number that looks wrong?